| Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help A SIOG surgical task force prospective study RA Audisio Critical Reviews in Oncology and Hematology, 2008 | 463 | 2008 |
| Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial EK Geissler, AA Schnitzbauer, C Zülke, PE Lamby, A Proneth, C Duvoux, ... Transplantation 100 (1), 116-125, 2016 | 445 | 2016 |
| 2018 annual report of the European Liver Transplant Registry (ELTR)–50‐year evolution of liver transplantation R Adam, V Karam, V Cailliez, JG O Grady, D Mirza, D Cherqui, ... Transplant International 31 (12), 1293-1317, 2018 | 270 | 2018 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, ... Journal of Clinical Oncology 39 (1), 66, 2021 | 263 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 230 | 2021 |
| Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ... The Lancet Oncology 21 (7), 947-956, 2020 | 226 | 2020 |
| Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ... Journal of hepatology 66 (3), 552-559, 2017 | 209 | 2017 |
| Patterns of hepatitis delta virus reinfection and disease in liver transplantation A Ottobrelli, A Marzano, A Smedile, S Recchia, M Salizzoni, C Cornu, ... Gastroenterology 101 (6), 1649-1655, 1991 | 201 | 1991 |
| A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for … AA Schnitzbauer, C Zuelke, C Graeb, J Rochon, I Bilbao, P Burra, ... BMC cancer 10, 1-8, 2010 | 186 | 2010 |
| Platelet‐derived growth factor‐D and Rho GTPases regulate recruitment of cancer‐associated fibroblasts in cholangiocarcinoma M Cadamuro, G Nardo, S Indraccolo, L Dall'Olmo, L Sambado, L Moserle, ... Hepatology 58 (3), 1042-1053, 2013 | 174 | 2013 |
| Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling L Fabris, M Cadamuro, M Guido, C Spirli, R Fiorotto, M Colledan, G Torre, ... The American journal of pathology 171 (2), 641-653, 2007 | 166 | 2007 |
| Monogenic diseases that can be cured by liver transplantation S Fagiuoli, E Daina, L D’Antiga, M Colledan, G Remuzzi Journal of hepatology 59 (3), 595-612, 2013 | 139 | 2013 |
| Delaying surgery for patients with a previous SARS-CoV-2 infection Journal of British Surgery 107 (12), e601-e602, 2020 | 137 | 2020 |
| Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation G Remuzzi, P Ruggenenti, M Colledan, B Gridelli, A Bertani, P Bettinaglio, ... American Journal of Transplantation 5 (5), 1146-1150, 2005 | 135 | 2005 |
| Split and whole liver transplantation outcomes: a comparative cohort study M Cardillo, N De Fazio, P Pedotti, T De Feo, LR Fassati, V Mazzaferro, ... Liver transplantation 12 (3), 402-410, 2006 | 131 | 2006 |
| Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease B Gridelli, M Spada, W Petz, A Bertani, A Lucianetti, M Colledan, ... Transplantation 75 (8), 1197-1203, 2003 | 118 | 2003 |
| Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) LS Belli, C Duvoux, T Artzner, W Bernal, S Conti, PA Cortesi, SC Sacleux, ... Journal of hepatology 75 (3), 610-622, 2021 | 112 | 2021 |
| mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors AA Schnitzbauer, N Filmann, R Adam, P Bachellier, WO Bechstein, ... Annals of surgery 272 (5), 855-862, 2020 | 105 | 2020 |
| Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization L Fabris, M Cadamuro, L Moserle, J Dziura, X Cong, L Sambado, G Nardo, ... Hepatology 54 (3), 890-899, 2011 | 103 | 2011 |
| A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ... Journal of hepatology 60 (2), 290-297, 2014 | 100 | 2014 |
Umberto CilloUnità di Chirurgia Epatobiliare e Trapianto Epatico, Università degli Studi di PadovaVerified email at unipd.it
